The WHO Guidelines on Ethical Issues in Public Health Surveillance is the first international framework of its kind, it fills an important gap. The goal of the guideline development project was to help policymakers and practitioners navigate the ethical issues presented by public health surveillance. This document outlines 17 ethical guidelines that can assist everyone involved in public health surveillance, including officials in government agencies, health workers, NGOs and the private sector.
|
This documentation was produced by Youth LEAD, The Regional Network of Young Key Population in Asia and Pacific as a showcase of our support and interventions to Young Key Populations from Indonesia, Pakistan and Vietnam who applied the Global Fund funding request as the first window applicants beginning from late 2016 to early 2017. It will examine Youth LEAD’s technical support to the country partners to encourage young key population capacity and involvement in the Global Fund country processes. These three countries selected as the case studies also received Youth LEAD direct grants under the GF-CRG Special Initiative grant via Robert Carr Network Fund between 2016-2017.
|
This year’s report showcases the many ways in which we support work at country and global level to turn the aims of the 2030 Agenda for Sustainable Development into results for women and girls worldwide, working closely with Member States and a wide range of partners to realize rights and build resilience. In 2016, the first year of implementing the Sustainable Development Goals, we supported women to claim their right to equal treatment under the law, to gain elected office, to draw on the power of innovation and technology, and to become leaders through sports, among many other initiatives. We also supported civil society and women’s rights activists to inform and influence crucial policy discussions.
Keywords: gender equality, women’s empowerment, post-2015 Development Agenda, SDGs
|
This Annual Report provides an overview of the first year of implementation of Phase III of the Global Programme (2016-2020) – highlighting the political and human rights dimensions of the rule of law and how our support contributes to sustaining peace. Part I, Year in Review, reflects on international policy developments affecting rule of law assistance and provides key country-level results achieved through the Global Programme in 2016. Part II, Country Profiles, presents an analysis of our engagement in 34 countries affected by crisis, conflict, and fragility. Lastly, Part III, provides detailed financial information on the Global Programme.
|
To celebrate 20 years since its inception, the World Drug Report 2017 is presented in a new five-booklet format designed to improve reader friendliness while maintaining the wealth of information contained within.
Booklet 1 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. Booklet 2 deals with the supply, use and health consequences of drugs. Booklet 3 focuses on the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis) and on the impact of new cannabis policies. Booklet 4 provides an extended analysis of the global synthetic drugs market and contains the bulk of the analysis for the triennial global synthetic drugs assessment. Finally, Booklet 5 contains a discussion on the nexus between the drug problem, organized crime, illicit financial flows, corruption and terrorism.
- Booklet 1 Executive summary - conclusions and policy implications
- Booklet 2 Global overview of drug demand and supply
- Booklet 3 Market analysis of plant-based drugs - Opiates, cocaine, cannabis
- Booklet 4 Market analysis of synthetic drugs
- Booklet 5 The drug problem and organized crime, illicit financial flows, corruption and terrorism
- World Drug Report 2017 - Factsheet
|
"Ten years in public health 2007-2017" chronicles the evolution of global public health during the tenure of Dr Chan, WHO Director-General. This series of chapters evaluates successes, setbacks, and enduring challenges during her administration. They show what needs to be done when progress stalls or new threats emerge. The chapters (links are below) show how WHO technical leadership can get multiple partners working together in tandem under coherent strategies. The importance of country leadership and community engagement is stressed repeatedly throughout the chapters.
Keywords: HIV, TB, hepatitis, universal health coverage (UHC), health care, data, treatment
|
PEPFAR’s focus on gaining sustainable control of the HIV epidemic made possible the announcement of bold PEPFAR HIV prevention and treatment targets for 2017 and 2018 at the 2016 Sustainable Development Goals Summit and the 2016 United Nations General Assembly. The focus on sustainable epidemic control began in 2014, when PEPFAR programs began pivoting to a data-driven approach that strategically targets geographic areas and populations where HIV/AIDS is most prevalent, and in which PEPFAR, in collaboration with host country governments, can achieve the greatest impact.
|
An Act to provide for the prevention and control of the spread of Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome and for the protection of human rights of persons affected by the said virus and syndrome and for matters connected therewith or incidental thereto.
|
Discrimination in health care settings is directed towards some of the most marginalized and stigmatized populations – the very populations that States promised to prioritize through the 2030 Agenda, and who are all too often excluded or left behind. Many individuals and groups face discrimination on the basis of their age, sex, race or ethnicity, health status, disability or vulnerability to ill health, sexual orientation or gender identity, nationality, asylum or migration status, or criminal record, often experiencing intersecting or compounding forms of discrimination.
Keywords: health care, discrimination, human rights, laws
|
People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
|